Zacks Investment Research
09 Sept 2026, 22:50 UTC · 1d ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
4 claims · each scored for market impact
Procter & Gamble is expected to report upcoming quarterly EPS of $1.89, a decrease of 5.03% from the prior-year quarter. — A year-over-year decline in earnings per share typically puts downward pressure on a stock price if it suggests slowing profitability.
-0.40Procter & Gamble is currently trading at a Forward P/E ratio of 20.84, which is a premium compared to its industry average of 18.62. — Trading at a premium relative to peers increases the risk of a price correction if the company fails to deliver superior growth.
-0.20Procter & Gamble's consensus revenue estimate for the upcoming quarter is $22.68 billion, representing a 1.33% increase from the previous year. — Modest revenue growth is generally positive but the low rate of increase may be viewed as stagnant for a company of this scale.
+0.10Continue reading
5 related stories
Top 2 movers · tap to explore
The Zacks Consensus EPS estimate for Procter & Gamble has moved 0.05% lower within the past month. — Negative analyst revisions, even small ones, often signal a deteriorating near-term outlook.
-0.10Which stocks this story touches
The stock underperformed the S&P 500 in the latest session and is facing a projected quarterly EPS decline of 5.03%.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Invezz
3h ago
